Niemann-Pick (NP) disease refers to a group of rare genetic disorders that cause lipids to build up in body tissues. This can harm many organs, including your brain, liver, lung and spleen. Symptoms often get worse over time. Treatments may help manage symptoms and slow disease progression, but most NP diseases are eventually fatal.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Niemann-Pick (NP) disease is an umbrella term for a group of rare diseases that cause fatty substances (lipids) to build up in different parts of your child’s body. The buildup of these lipids damages different organs and tissues and keeps them from working properly. Symptoms — like lung, liver and neurological problems — gradually get worse over time, leading to life-threatening complications. These diseases often lead to premature death.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Healthcare providers usually diagnose these diseases in infants and children. But symptoms can also appear for the first time in adolescents and adults. Treatments can manage symptoms and, sometimes, prevent the disease from getting worse for a little while. Providers do whatever they can to keep you or your child comfortable and support your family.
There are two distinct disorders within the Niemann-Pick umbrella:
ASMD and NPC are both examples of inherited metabolic disorders. Specifically, providers classify them as lysosomal disorders. With these disorders, substances that your body normally breaks down (like lipids) build up and become toxic.
ASMD occurs when a certain enzyme called acid sphingomyelinase (ASM) isn’t working as expected. Normally, ASM breaks down a lipid called sphingomyelin. But when ASM is “deficient,” or not doing as much as it should, sphingomyelin and other lipids start to build up inside cells. Cells are tiny building blocks that make up all our organs and tissues. As these lipids accumulate, they prevent cells from working normally.
Advertisement
ASMD can affect nearly all the cells in a person’s body. But the disease often has the most severe effect on cells in these areas:
ASMD further breaks down into the following types:
Experts estimate that ASMD affects anywhere from 1 in 100,000 to 1 in 1,000,000 live births around the world — often quoted as 1 in 250,000. There’s a higher prevalence of ASMD type A among people of Ashkenazi Jewish descent.
Niemann-Pick disease type C occurs when certain proteins (NPC1 or NPC2) aren’t working as expected. These proteins help cholesterol and other lipids move from one spot to another within cells. When lipids can’t move properly within cells, they build up in different tissues in your body — including brain tissue.
Providers classify NPC according to the age when symptoms begin. They generally use these five categories:
Experts estimate that NPC affects at least 1 in 100,000 live births.
Symptoms vary based on the type of disease.
ASMD symptoms occur on a spectrum from mild to severe. While there’s some overlap between types, type A has the most severe symptoms that are quickly life-threatening.
ASMD type A (infantile neurovisceral) symptoms appear soon after birth and worsen fast. Infants with this condition typically:
ASMD type A/B (chronic neurovisceral) and ASMD type B (chronic visceral) have a wide range of symptoms. These range from mild to severe and can start any time from early childhood to adulthood.
Advertisement
Possible signs and symptoms include:
Type B doesn’t have neurological symptoms. But type A/B often does. Possible neurological symptoms with type A/B — in addition to some or all of the visceral symptoms mentioned above — include:
Providers often describe NPC symptoms as visceral, neurological or psychiatric:
Advertisement
Below are possible symptoms within each category.
The most common complications and causes of death vary by disease.
Advertisement
ASMD:
NPC:
Gene variations cause ASMD and Niemann-Pick disease type C. The specific genes that are changed vary by disease.
Changes to the SMPD1 gene cause ASMD. This gene tells your body how to make the ASM enzyme that breaks down certain lipids. Researchers have found over 250 different SMPD1 variants (changed versions of a gene) that cause ASMD. That’s why people with ASMD have such a wide range of symptoms and severity levels. It depends on the specific variant they inherit and how it affects ASM function.
These gene variations pass down within biological families. This means parents can pass a gene variant down to their biological children. ASMD follows an autosomal recessive pattern of inheritance. You need to receive two copies of the changed gene (one from each parent) to develop the disease. If you receive just one copy, you’re a carrier but won’t have symptoms.
Full siblings of someone with ASMD are expected to have a 25% chance of having ASMD, as well.
Changes to the NPC1 gene or NPC2 gene cause Niemann-Pick disease type C. These genes tell your body how to make certain proteins (NPC1 and NPC2) that help cholesterol and other lipids move within cells. A change to either gene causes lipids to build up in body tissues.
NPC also follows an autosomal recessive pattern of inheritance. But carriers may have some mild symptoms of NPC themselves. Siblings of someone with NPC have a 25% chance of also having it.
ASMD and NPC are rare diseases that can be challenging for providers to diagnose. This is especially true when symptoms start later in life. In general, providers use a person’s symptoms, medical history and test results to reach a diagnosis.
Usually, red flags pop up that make a provider first suspect a possible Niemann-Pick diagnosis. For example, your child might have a certain combination of symptoms typical of NPC. Or routine lab or imaging testing might show common features of ASMD (like low platelets, high blood lipids or increased liver and spleen size).
If providers suspect ASMD or NPC, they’ll do specific tests to confirm a diagnosis. These might include:
There’s no cure for ASMD or NPC. But in many cases, medications, therapies and other treatments can help your child manage symptoms and function at their best.
Olipudase alfa (Xenpozyme®), a type of enzyme replacement therapy, is currently the only treatment that directly targets the cause of ASMD. Providers give your child medicine through an IV. This medicine provides your child with functional ASM enzymes to replace the ones that aren’t working right. This treatment can help:
Enzyme replacement therapy doesn’t improve symptoms related to central nervous system function.
With NPC, providers focus on treating the neurological symptoms. These symptoms typically get worse over time. Certain medications may slow down this process. Your child’s care team may prescribe one or more of the following:
Providers may also prescribe specific medications to help with delusions, depression, hallucinations, muscle weakness or seizures.
Your child’s care team may recommend therapies or other treatments. These vary according to the type of disease your child has and how it affects their body. Possibilities include:
Your child’s care team can give you the most accurate sense of what you might expect. Life expectancy varies widely and depends on:
In general:
Learning your child has ASMD or Niemann-Pick disease type C can feel isolating or overwhelming. You might feel like so much is out of your control. And it’s hard to live with uncertainty. Take some comfort in knowing researchers continue learning more about these and other rare diseases every day.
Your child’s care team will keep a close eye on your child’s condition. They’ll recommend treatments as needed to help your child live their best life possible. They can also connect you with resources and support groups.
If you have a neurological condition, you want expert advice. At Cleveland Clinic, we’ll work to create a treatment plan that’s right for you.

Last reviewed on 12/23/2025.
Learn more about the Health Library and our editorial process.